sizofiran has been researched along with asialo gm1 ganglioside in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asano, T; Inoue, M; Matsutani, M; Sato, S; Tsuchiya, Y; Yajima, M | 1 |
| Arika, T; Nakahashi, S; Tsuchiya, Y; Yang, ZB | 1 |
| Hashimoto, J; Kakuta, H; Kano, Y | 1 |
3 other study(ies) available for sizofiran and asialo gm1 ganglioside
| Article | Year |
|---|---|
Effect of a glucan, sizofiran, on natural-killer activity of 5-fluorouracil-treated murine bone marrow cells.
Topics: Animals; Bone Marrow; Cell Division; Cells, Cultured; Fluorouracil; G(M1) Ganglioside; Glycosphingolipids; Killer Cells, Natural; Male; Mice; Mice, Inbred C3H; Sizofiran | 1991 |
Acceleration of natural killer (NK) cell recovery by a glucan, sizofiran, in anti-asialoGM1 antibody-treated mice.
Topics: Animals; Antigens, Surface; Bone Marrow Cells; Cytotoxicity Tests, Immunologic; Fluorouracil; G(M1) Ganglioside; Glucans; Interleukin-3; Interleukin-6; Killer Cells, Natural; Male; Mice; Mice, Inbred C3H; Mice, Inbred DBA; Rabbits; Sizofiran; Spleen; Tumor Cells, Cultured | 1993 |
Inhibitory effect of metastasis by combined administration with interleukin-2 and sizofiran, a single glucan--immunohistochemical study.
Topics: Animals; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Female; G(M1) Ganglioside; Immunohistochemistry; Interleukin-2; Liver; Lymphoma; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Recombinant Proteins; Sizofiran; Spleen | 1996 |